Prodia Diagnostic Line Tbk vs Indo Straits Tbk. — how do they compare? Prodia Diagnostic Line Tbk trades at Rp270 (market cap 470.58B, 28.43M 24h volume), while Indo Straits Tbk. trades at Rp264 (market cap 146.34B, 34.6K 24h volume). The key difference: Prodia Diagnostic Line Tbk is far larger — about 3.2× Indo Straits Tbk.'s market cap, and Prodia Diagnostic Line Tbk is more actively traded (28.43M versus 34.6K). Which is the better fit depends on your goals.
| PRDL | PTIS | |
|---|---|---|
Market Cap | 470.58B | 146.34B |
Volume | 28.43M | 34.6K |
Lot | 284.34K | 346 |
Turnover | 7.8B | 9.19M |
Average Price | 274.19 | 265.65 |
Value | 7.8B | 9.19M |
Indicative Equilibrium Price | 270 | 266 |
Indicative Equilibrium Volume | 2.1K | 900 |
Trailing returns across standard periods
Latest headlines on both assets
PT Prodia Diagnostic Line Tbk (the Company) was established April 16, 2010 with the name of PT DiaLine Systems Indonesia based on Notarial Deed No. 22 of Rismalena Kasri, S.H. On April 25, 2011, PT DiaLine Systems Indonesia changed the Companys name to PT Prodia Diagnostic Line based on Notarial Deed No. 14 of Rismalena Kasri, S.H. The Company is in the form of a Limited Liability Company in 2010 and began commercial production in 2011. The production results are marketed locally. The parent and ultimate parent entity of the Company is PT Prodia Utama.
Read more on PRDL →PT Indo Straits (the "Company") was established based on Notarial Deed No 319 of Ridwan SH, dated January 21, 1985. The Company's Articles of Association have been amended several times. The latest amendment was based on Notarial Deed No. 4 of Leolin Jayanti SH dated March 8, 2011 pertaining of change composition of the Company's board of Commissioners and Boards of Directors, issuance of new share to be offered to the public in the Initial Public Offering, and amendment of the Article of Association of the Company to become a public entity.
Read more on PTIS →